Suzuki et al. revealed that blocking TGF-β signal transduction significantly enhanced the anti-tumor response of CD8+ T cells, and ultimately inhibited the growth of malignant mesothelioma (Suzuki et al., 2007). The gene discussed is CD8A; the disease is malignant mesothelioma.